Question 1

Do we offer FFDM training?

Accepted Answer

Yes. Each activity involving mammography incorporates FFDM.

Question 2

What is the MQSA?

Accepted Answer

FDA explains MQSA: The Mammography Quality Standards Act requires mammography facilities across the nation to meet uniform quality standards. Congress passed this law in 1992 to assure high-quality mammography for early breast cancer detection, which can lead to early treatment, a range of treatment options leading to an increased chance of survival....

Question 3

MQSA Compliance Update: What do Interpreting Physicians Need to Know Now?

Accepted Answer

Staying compliant with MQSA guidelines is critical, especially with the recent ACR revisions (May 22, 2024). These updates bring important changes, particularly regarding documentation accessibility and ongoing requirements, and failing to keep up can lead to significant citations. The "Golden Rule" of Documentation: On-Site and Accessible! The most impactful shift in the recent ACR guidance is the immediate accessibility of all qualification documentation on-site for annual inspections. FDA inspectors are now issuing Level 3 citations for facilities unable to produce these records on demand. Action Item: Ensure your initial and continuing qualification forms are readily available at every facility where you interpret. Don't let them be "filed away" at corporate. Maintaining Your Status: Continuous Compliance is Key MQSA operates on a rolling timeline, demanding active maintenance of your metrics. This includes interpreting 960 mammographic exams every 24 months, earning 15 Category 1 CME credits in mammography every 36 months, and completing 8 hours of specific training for any new modality before independent use.

Question 4

What is the process for satisfying initial modality training requirements for the Mammography Quality Standards Act (MQSA) through CME?

Accepted Answer

Physicians can fulfill the MQSA initial modality training requirements by completing accredited CME courses specific to the new breast imaging modality (e.g., Digital Breast Tomosynthesis).